pre-IPO PHARMA
COMPANIES VC JOBS NEWS CONTACT

COMPANY OVERVIEW

E-Scape Bio is a preclinical stage biopharmaceutical company focused on the discovery and development of small molecule drugs to treat genetically-defined subpopulations in neurodegenerative diseases.

LOCATION

  • South San Francisco, CA, USA

    • THERAPEUTIC AREAS

  • Neurodegenerative Disease

  • Rare Diseases

    • WEBSITE

    https://www.e-scapebio.com

    CAREER WEBSITE

    https://www.e-scapebio.com/careers/index.php

    SOCIAL MEDIA

    INVESTORS

    abbvie-ventures jjdc lilly-asia-ventures novartis-venture-fund novo-holdings orbimed osage-university-partners

    PRESS RELEASES


    Dec 19, 2019

    E-Scape Bio Appoints Anthony Rimac as Chief Financial Officer and Ann Kapoun, Ph.D., as SVP of RandD


    Jan 3, 2019

    E-Scape Bio Appoints Dr. Carrolee Barlow as Chief Medical Officer


    Aug 23, 2018

    E-Scape Bio Appoints Biopharma Industry Veteran Julie Anne Smith As President and Chief Executive Officer


    Jun 12, 2018

    E-Scape Bio Obtains Worldwide Rights from AbbVie for Selective S1P5 Program Targeting CNS-related Lysosomal Storage Disorders


    Jul 12, 2017

    E-Scape Bio Series A Extension Brings Total Round to $63 Million to Fund Neurodegenerative Disease Pipeline


    For More Press Releases
    Google Analytics Alternative